366 related articles for article (PubMed ID: 2220877)
1. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL
Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
[TBL] [Abstract][Full Text] [Related]
3. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure.
Zappacosta AR; Perras ST; Bell A
Am J Med; 1991 Sep; 91(3):229-32. PubMed ID: 1892142
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group.
Am J Kidney Dis; 1991 Jul; 18(1):50-9. PubMed ID: 2063855
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
6. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
Sinai-Trieman L; Salusky IB; Fine RN
J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial.
Lim VS; DeGowin RL; Zavala D; Kirchner PT; Abels R; Perry P; Fangman J
Ann Intern Med; 1989 Jan; 110(2):108-14. PubMed ID: 2909202
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal administration of recombinant human erythropoietin.
Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
[TBL] [Abstract][Full Text] [Related]
10. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
[TBL] [Abstract][Full Text] [Related]
11. [Correction of anemia in chronic kidney failure with lyophilized recombinant human erythropoietin using a subcutaneous approach].
Amar M; Cendoroglo Neto M; Canziani ME; Nadaletto MA; Ajzen H; Draibe SA
Rev Assoc Med Bras (1992); 1994; 40(2):101-7. PubMed ID: 7820145
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
[TBL] [Abstract][Full Text] [Related]
13. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease.
Muirhead N; Churchill DN; Goldstein M; Nadler SP; Posen G; Wong C; Slaughter D; Laplante P
Am J Nephrol; 1992; 12(5):303-10. PubMed ID: 1488998
[TBL] [Abstract][Full Text] [Related]
14. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
Campos A; Garin EH
Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
[TBL] [Abstract][Full Text] [Related]
15. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial.
Kleinman KS; Schweitzer SU; Perdue ST; Bleifer KH; Abels RI
Am J Kidney Dis; 1989 Dec; 14(6):486-95. PubMed ID: 2688405
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.
Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR
Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin treatment of anemia in renal transplant patients.
Lezaic V; Djukanovic L; Pavlovic-Kentera V
Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous recombinant human erythropoietin in chronic renal allograft dysfunction.
Aufricht C; Marik JL; Ettenger RB
Pediatr Nephrol; 1998 Jan; 12(1):10-3. PubMed ID: 9502558
[TBL] [Abstract][Full Text] [Related]
19. Clinical and blood rheologic stability in erythropoietin-treated predialysis patients.
Brown CD; Friedman EA
Am J Nephrol; 1990; 10 Suppl 2():29-33. PubMed ID: 2260615
[TBL] [Abstract][Full Text] [Related]
20. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
Allegra V; Martimbianco L; Vasile A
Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
